White Rock's 2019 program remains on track

|

Published 13-SEP-2019 11:32 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

White Rock Minerals Ltd (ASX:WRM) today provided an update on its work at the globally significant Red Mountain high-grade zinc and precious metals VMS project in central Alaska – otherwise known as the Red Mountain Project.

White Rock reminded the market this morning that there are already two high grade deposits at the Red Mountain Project, with an Inferred Mineral Resource of 9.1 million tonnes @ 12.9% ZnEq for 1.1 million tonnes of contained zinc equivalent at Dry Creek and WTF.

The company’s summer field exploration activities have focused on defining and drill testing new targets that could yield a significant discovery to support a greenfield development scenario.

This back half of 2019, has seen White Rock focus its drilling on three new target areas: Arete, Smog South and Sheep Rogers.

The Arete and Sheep-Rogers target are within an extensive alteration zone with 10km of strike, where multiple prospective occurrences containing sulphide accumulations, chert and iron formations have been identified. These are all believed to be proximal to horizons prospective for base metal rich massive sulphides along strike and down dip.

The Smog South prospect is a large isolated target area further east along the Glacier Trend also with extensive alteration, anomalous geochemistry plus surface base metal mineralisation within a VMS horizon at the Smog prospect to the north.

WRM also has its drill sights on further target areas including Artesia, Irish Knob, Black Top, Grizzly, Kettle and Glacier Creek East. All target areas, including those drilled recently with only one hole at each, contain numerous prospective horizons, geochemical anomalies and EM conductivity features to be drill tested.

This drilling has provided important stratigraphic information.

White Rock has also focused on acquiring new regional surface geochemistry across the expanded tenement package and the intervening prospective stratigraphic package to the south and west.

A sampling survey was completed with >1,000 samples collected over the 800km2 area extending from Sheep Creek in the west through to Anderson Mountain in the south and West Fork to the east. Historic VMS occurrences here led to WRM expanding its strategic tenement package from 143km2 to 475km2 in late-2018

Assays for 18 samples here averaged 5.6% Zn, 1.7% Pb, 49g/t Ag & 0.5% Cu3.

Here’s a look where WRM is conducting its activities:

Location of 2019 drilling activities on the DGGS geology map (after Freeman et al., 2016) and terrain surface with locations for the Dry Creek and WTF VMS deposits.

The current program has seen WRM drill 11 holes with mixed results, however drilling at Dry Creek is now targeting the down-dip projection of mineralisation 200 metres deeper than previously drilled. Should a successful drill test provide a significant step-out from the known high-grade Resource, it will help illustrate the upside size potential of the Dry Creek deposit and underpin the potential of the project for further development studies.

This suggests there is still plenty of work to do and therefore further, potentially positive news to come.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X